AJ Ally
AJ Ally is a principal and pharmacy management consultant with the Chicago office of Milliman. He joined the firm in 2019.
Experience
AJ joined the firm as a strategist and currently leads strategic client engagements to solve the most pressing issues in healthcare today. He is a licensed pharmacist with 25 years of experience in life science, pharmacy, and managed care. He has deep expertise in the pharmacy supply chain, PBM pricing strategies, operations, formulary rebates, 340B, specialty pharmacy, and benefit designs. He has also worked with all types of payers, supporting strategy and implementation. AJ’s previous roles as Vice President of Pharmacy and Vice President of Strategy encouraged transformation and transparency in the pharmacy supply chain and introduced new plan designs and the use of technology to improve provider-patient relationships. AJ was also instrumental in introducing new PBM solutions in the market that reduced total cost and increased member access, including launching the first PBM narrow formulary. AJ also spent several years at Hewitt Associates, consulting for Fortune 500 employers with designing and managing their pharmacy and health and welfare benefits. Over the past two decades, AJ has been a frequent speaker at conferences and is considered by his peers as a thought leader in Pharmacy Benefits and the Pharmacy Supply Chain.
- Ally, A., Melody Craff, Kim Ren., et al. “Measuring how GLP-1 medications impact the total cost of care.” August 2025.
- Ally, A., Alan Van Amber., et al. “Reimagining Pharmacy Channel Reimbursement within the Supply Chain.” March 2025.
- Ally, A., M. Brady, et al. “GLP-1 market update and what’s next.” November 2024, Annual IFEBP.
- Ally, A., Gruenhaupt, M., et al. "Payer Strategies for GLP-1 Medications for Weight Loss." August, 2023.
- Ally, A., Berman, M., "Potential Policy Changes that Could Upend Drug Prices." PM360, April 2022.
- Ally, A., Berman, M., Pierce, K., Klein, M., "The Inflation Reduction Act Passed, Now What?" PM360, September 2022.
- Ally, A. et al., "Specialty Pharmacy Innovation in the Supply Chain." Asembia, 2022.
- Ally, A. and Henshaw, J., Milliman Healthcare Intelligence Client Forum, “Rebate GPOs role in the Pharmacy Supply Chain.” October 2021.
- Ally, A., et al., "PBM Pricing Tactics in State Managed Medicaid Plans." Milliman Medicaid Client Forum, 2021.
- Ally, A., et al., "Pharmacy Benefit Management Innovation Symposium." Nephron Research, October 2020.
- Ally, A., “Pharmacy Innovation, a Glance into the Future.” CBI 5th Annual PBM Contracting, July 2019.
- Ally, A. and George, S., “The Role of the Institute for Clinical and Economic Review in Reviewing New and Innovative Products.” ArtSci Innovative Contracting Bootcamp, November 2019.
- Ally, A. “Is drug price transparency to consumers possible?” SS&C Blog. 2018. www.ssctech.com/blog Is drug price transparency to consumers possible? (ssctech.com)
- Ally, A., “Formulary Innovations in a Changing Pharmaceutical Landscape.” CVS Health, June 2012.
- Ally, A., “Plan Strategies to Control Cost and Trend.” Drug Benefit News, August 2011.
- Ally, Brennan, Liberman, and Moore, “Effectiveness of physician alerts to resolve potential gaps in pharmacotherapy.” American Health & Drug Benefits, May / June 2010.
- Ally, A., “Optimizing Generic Utilization Through Progressive Plan Designs.” AMCP, October 2009.
- Member, Academy of Managed Care Pharmacy
- Licensed Pharmacist, New York
- MBA, State University of New York at Buffalo